Last news
Messenger Biopharma launches the commercialization of its Nuntius biotechnology
posted October 10, 2024
Find us
Messenger Biopharma is perfecting a biotechnology of in vivo mRNA transfection, which has been patented. This biotechnology tends to optimize the process of mRNA delivery to mammalian cells, as well as the mRNA sequence.
News
Messenger Biopharma launches the commercialization of its Nuntius biotechnology
October 10, 2024
OST Group becomes a shareholder in July 2019
July 08, 2019